Ownership history in Parkwood LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Parkwood LLC reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 275,000 | — | 0% | 0.18% | $1.9M | $7.05 |
| 2025 Q2 | UNCHANGED | 275,000 | — | 0% | 0.16% | $1.8M | $6.50 |
| 2025 Q1 | UNCHANGED | 275,000 | — | 0% | 0.20% | $2.2M | $7.93 |
| 2024 Q4 | ADDED | 275,000 | +254,619 | +1249.3% | 0.40% | $3.5M | $12.67 |
| 2023 Q1 | ADDED | 20,381 | +1,028 | +5.3% | 0.04% | $272K | $13.37 |
| 2022 Q4 | ADDED | 19,353 | +878 | +4.8% | 0.06% | $416K | $21.52 |
| 2022 Q3 | INITIATED | 18,475 | — | — | 0.06% | $370K | $20.03 |
As of 2025 Q4 — sorted by position size